Psoriatic arthritis (PsA), a heterogeneous chronic inflammatory immune-mediated disease
characterized by musculoskeletal inflammation (arthritis, enthesitis, spondylitis, and …

Metabolomics is one of the most promising 'omics' sciences for the implementation in
medicine by developing new diagnostic tests and optimizing drug therapy. Since in …

Introduction Diseases related to chronic persisting inflammation are amongst the largest
sources of morbidity and health costs, yet biomarkers for early diagnosis, prognosis, and …

Achieving a good outcome for a person with Psoriatic Arthritis (PsA) is made difficult by late
diagnosis, heterogenous clinical disease expression and in many cases, failure to …

Recently, the concept of a mass spectrometric blood metabogram was introduced, which
allows the analysis of the blood metabolome in terms of the time, cost, and reproducibility of …

Psoriatic arthritis (PsA) is a chronic inflammatory immune-mediated disease that affects
approximately 30% of psoriasis patients. In most cases, skin disease clearly precedes the …

Background Currently, there has been observed a significant alteration in the composition of
the gut microbiome (GM) and serum metabolites in patients with psoriatic arthritis (PsA) …

ABSTRACT Introduction Psoriatic arthritis (PsA) is a chronic, immune-mediated disease
characterized by synovio-entheseal inflammation. It is estimated to affect around 30% of …

Background Psoriatic arthritis (PsA) is a chronic inflammatory musculoskeletal disease
involving several articular and extra-articular structures. Despite the important progresses …

The clinical blood metabogram (CBM) was developed to match a tailored analysis of the
blood metabolome to the time, cost, and reproducibility constraints of clinical laboratory …